Analytical screening of polymorphic variants of 20S proteasome genes when planning a study of pathogenetic effects of modification of NFKB1 post-translational processing

Aim. Formation of polymorphic variants panel of the proteasome genes 20S, potentially significant for the study as balance modifier factors of p105/p50 NFKB1.
Materials and methods. Determination of genes that encode proteins of the multisubunit proteasome complex prospective for research purposes, was carried out on the basis of information retrieved from eLIBRARY and PubMed. The source of information for the formation of polymorphic variants panel of genes (SNP, single nucleotide polymorphism) was the Ensembl genomic browser, http://www.ensembl.org. The structure of genes is described by the NCBI (databases Gene, http:// www.ncbi.nlm.nih.gov/gene). The panel was filled with the minor allelic frequency in the population (MAF), the localization of SNP in the gene structure and the availability of data on the relationship with multifactorial diseases and other effects in mind. To calculate the genetic distances between populations, we used the methord of comparing the populations by frequencies of polymorphic marker alleles proposed by Ney, the obtained matrices are illustrated by the method of multidimensional scaling in space using Statistica v.8.0.
Results. Discussion of the algorithm and results of analytical screening of polymorphic variants of 14 genes (PSMA1-PSMA7, PSMB1–PSMB7) encoding proteasome subunits 20S. The characteristics of the SNP panel are given, compiled with the selection criteria taken into account. According to the data on the frequencies of polymorphic gene variants, the features of global and European population gene pools (283 SNP), as well as samples from Russian populations (20 SNP) are analyzed. Based on the results of the analysis of information on the associations of selected SNPs with various diseases, a panel (42 SNPs) of 20S proteasome genes was formed, potentially significant for the study as factors modifying the p105/p50 NFKB1 balance.
Conclusion. Annotation of the formed panel of SNP genes of the 20S proteasome with MAF>0.1 indicates the potential role of polymorphism in the pathogenesis of diseases of various profiles. This may be of research interest to the formed panel in context of implementation of traditional approaches – the search for candidate genes based on the analysis of associations with diseases, as well as the analysis of the influence of SNP on the level of genetic expression, synthesis of gene products, NFKB1 processing and p105/p50 balance in silico and on model objects.

1. Meyer AV, Tolochko TA, Astafyeva EA, Ulyanova MV, Imekina DO, Lavryashina MB. Contribution of polymorphic variants of the NFKB1 transcription factor gene to the development of multifactorial diseases with an infammatory component. Fundamental and Clinical Medicine. 2022;7(2):112-124. (In Russ). https://doi.org/10.23946/2500-0764-2022-7-2-112-124

2. Rape M, Jentsch S. Productive RUPture: activation of transcription factors by proteasomal processing. Biochim Biophys Acta. 2004;1695(1-3):209-13. https://doi.org/10.1016/j.bbamcr.2004.09.022

3. Moorthy AK, Savinova OV, Ho JQ, Wang VYa-F, Vu D, Ghosh G. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner. EMBO J. 2006;25(9):1945-56. https://doi.org/10.1038/sj.emboj.7601081

4. Вeinke S, Deka J, Lang V, Belich MP, Walker PA, Howell S, Smerdon SJ, Gamblin SJ, Ley SC. NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity. Mol Cell Biol. 2003;23(14):4739-52. https:// doi.org/10.1128/MCB.23.14.4739-4752.2003

5. Li Z, Zhang J, Chen D, Shu HB. Casper/c-FLIP is physically and functionally associated with NF-kappaB1 p105. Biochem Biophys Res Commun. 2003;309(4):980-5. https://doi.org/10.1016/j.bbrc.2003.08.104

6. Perkins ND. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene. 2006;25(51):6717-30. https://doi.org/10.1038/sj.onc.1209937

7. Barrie ES, Hartmann K, Lee SH, Frater JT, Seweryn M, Wang D, Sadee W. The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations. Hum Mutat. 2017;38(1):112-119. https://doi.org/10.1002/humu.23135

8. Lee SH, Ahn WY, Seweryn M, Sadee W. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence. BMC Genomics. 2018;19(1):826. https://doi.org/10.1186/s12864-018-5219-3

9. Ohi K, Kuwata A, Shimada T, Kataoka Y, Yasuyama, Uehara T, Kawasaki Y. Genome-Wide Variants Shared Between Smoking Quantity and Schizophrenia on 15q25 Are Associated With CHRNA5 Expression in the Brain. Schizophrenia Bulletin. 2019;45(4):813-823. https:// doi.org/10.1093/schbul/sby093

10. Nguyen JDU, Lamontagne M, Couture C, Conti M, Paré PD, Sin DD, Hogg JC, Nickle D, Postma DS, Timens W, Laviolette M, Bossé Yo. Susceptibility loci for lung cancer are associated with mRNA levels of nearby genes in the lung. Carcinogenesis. 2014;35(12):2653-2659. https://doi.org/10.1093/carcin/bgu184

11. Amos CI, Gorlov IP, Dong Q, Wu X, Zhang H, Lu EY, Scheet P, Greisinger AJ, Mills GB, Spitz MR. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst. 2010;102(15):1199-205. https://doi.org/10.1093/jnci/djq232

12. O'Brien KM, Sandler DP, Shi M, Harmon QE, Taylor JA, Weinberg CR. Genome-Wide Association Study of Serum 25-Hydroxyvitamin D in US Women. Front Genet. 2018;9:67. https://doi.org/10.3389/fgene.2018.00067

13. Christakoudi S, Evangelou E, Riboli E, Tsilidis KK. GWAS of allometric body-shape indices in UK Biobank identifies loci suggesting associations with morphogenesis, organogenesis, adrenal cell renewal and cancer. Sci Rep. 2021;11(1):10688. https://doi.org/10.1038/s41598-021-89176-6

14. Rogne T, Liyanarachi KV, Rasheed H, Thomas LF, Flatby HM, Stenvik J, Løset M, Gill D, Burgess S, Willer CJ, Hveem K, Åsvold BO, Brumpton BM, DeWan AT, Solligård E, Damås JK. GWAS Identifies LINC01184/SLC12A2 as a Risk Locus for Skin and Soft Tissue Infections. J Invest Dermatol. 2021;141(8):2083-2086.e8. https://doi.org/10.1016/j.jid.2021.01.020

15. Paramonova N, Kalnina J, Dokane K, Dislere K, Trapina I, Sjakste T, Sjakste N. Genetic variations in the PSMA6 and PSMC6 proteasome genes are associated with multiple sclerosis and response to interferon-β therapy in Latvians. Exp Ther Med. 2021;21(5):478. https://doi.org/ 10.3892/etm.2021.9909

16. Deng J, Tan H, Hu J, Su G, Cao Q, Huang X, Zhou C, Wang Y, Kijlstra A, Yang P. Genetic aspects of idiopathic paediatric uveitis and juvenile idiopathic arthritis associated uveitis in Chinese Han. Brit. J. Ophthalmol. 2020;104(3):443-447. https://doi.org/10.1136/bjophthalmol-2018-313200.

17. Bakutenko IY, Hileuskaya ID, Nikitchenko NV, Sechko EV, Tchitchko AM, Batyan GM, Sukalo AV, Ryabokon NI. Polymorphism of Proteasomal Genes Can Be a Risk Factor for Systemic Autoimmune Diseases in Children. J. Ped. Genet. 2021;10(2):98-104. https://doi.org/10.1055/s-0040-1714697

18. Sjakste T, Paramonova N, Osina K, Dokane K, Sokolovska J, Sjakste N. Genetic variations in the PSMA3, PSMA6 and PSMC6 genes are associated with type 1 diabetes in Latvians and with expression level of number of UPS-related and T1DM-susceptible genes in HapMap individuals. Mol. Genet. Genomics. 2016;291(2):891-903. https://doi.org/10.1007/s00438-015-1153-0

19. Тamasauskiene L, Zemeckiene Z, Sakalauskas R, Sitkauskiene B. Expectancy of asthma phenotype having different polymorphism of PSMA6, PSMC6, PSMA3 proteasomal genes: Lithuanian study. World Allergy Organization Journal. 2015;8(Suppl 1):A154. https://doi.org/10.1186/1939-4551-8-S1-A154

20. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatorysignalling. Semin. Immunol. 2000;12(1):85-98. https://doi.org/10.1006/smim.2000.0210

21. Liu X, Wang X, Shen Y, Wu L, Ruan X, Lindpaintner K, Yusuf S, Engert JC, Anand S, Tan X, Liu L. The functional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese population. Atherosclerosis. 2009;206(1):199-203. https://doi.org/ 10.1016/j.atherosclerosis.2009.02.004

22. Ozaki K, Sato H, Iida A, Mizuno H, Nakamura T, Miyamoto Y, Takahashi A, Tsunoda T, Ikegawa S, Kamatani N, Hori M, Nakamura Y, Tanaka T. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet. 2006;38(8):921-5. https://doi.org/10.1038/ng1846

23. Bennett DA, Xu P, Clarke R, Zondervan K, Parish S, Palmer A, Cardon L, Peto R, Lathrop M, Collins R. The exon 1-8C/G SNP in the PSMA6 gene contributes only a small amount to the burden of myocardial infarction in 6946 cases and 2720 controls from a United Kingdom population. Eur J Hum Genet. 2008;16(4):480-6. https://doi.org/10.1038/sj.ejhg.5201948

24. Wang H, Jiang M, Zhu H, Chen Q, Gong P, Lin J, Lu J, Qiu J. Quantitative assessment of the influence of PSMA6 variant (rs1048990) on coronary artery disease risk. Mol Biol Rep. 2013;40(2):1035-41. https://doi.org/10.1007/s11033-012-2146-2

25. Heckman MG, Soto-Ortolaza AI, Diehl NN, Rayaprolu S, Brott TG, Wszolek ZK, Meschia JF, Ross OA. Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic stroke. Eur J Neurol. 2013;20(2):300-8. https:// doi.org/ 10.1111/j.1468-1331.2012.03846.x

26. Misra S, Kumar P, Kumar A, Sagar R, Chakravarty K, Prasad K. Genetic association between inflammatory genes (IL-1α, CD14, LGALS2, PSMA6) and risk of ischemic stroke: A meta-analysis. Meta Gene. 2016;8:21-9. https://doi.org/10.1016/j.mgene.2016.01.003

27. Zhu Z, Guo Y, Shi H, Liu C-L, Panganiban RA, Chung W, O'Connor LJ, Himes BE, Gazal S, Hasegawa K, Camargo CA, Qi L, Moffatt MF, Hu FB, Lu Q, Cookson WOC, Liang L. Shared genetic and experimental links between obesity-related traits and asthma subtypes in UK Biobank. J Allergy Clin Immunol. 2020;145(2):537-549. https:// doi.org/ 10.1016/j.jaci.2019.09.035

28. Zhang X, Johnson AD, Hendricks AE, Hwang S-J, Tanriverdi K, Ganesh SK, Smith NL, Peyser PA, Freedman JE, O'Donnell CJ. Genetic associations with expression for genes implicated in GWAS studies for atherosclerotic cardiovascular disease and blood phenotypes. Hum Mol Genet. 2014;23(3):782-95. https://doi.org/10.1093/hmg/ddt461

29. Marques H, Freitas J, Medeiros R, Longatto-Filho A. Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability. Int J Mol Epidemiol Genet. 2016;7(3):126-136.

30. Minelli A, Magri C, Barbon A, Bonvicini C, Segala M, Congiu C, Bignotti S, Milanesi E, Trabucchi L, Cattane N, Bortolomasi M, Gennarelli M. Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder. Translational Psychiatry. 2015;5(12):e687. https://doi.org/10.1038/tp.2015.180

31. Srivastava A, Singh P, Gupta H, Kaur H, Kanojia N, Guin D, Sood M, Chadda RK, Yadav J, Vohora D, Saso L, Kukreti R. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk. Int. J. Mol. Sci. Int. J. Mol. Sci. 2019;20(8):1993. https://doi.org/10.3390/ijms20081993

32. Varga G, Mikala G, Kiss KP, Kosóczki É, Szabó E, Meggyesi N, Balassa K, Kövy P, Tegze B, Szombath G, Tordai A, Andrikovics H, Homolya L, Masszi T. Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia. 2017;17(11):734-742. https://doi.org/10.1016/j.clml.2017.06.034

33. Wu F, Han X, Liu J, Zhang Z, Yan K, Wang B, Yang L, Zou H, Yang C, Huang W, Jin L, Wang J, Qian F, Niu Z. An ankylosing spondylitis risk variant alters osteoclast differentiation. Rheumatology (Oxford). 2023;62(5):1980-1987. https://doi.org/10.1093/rheumatology/keac542

34. Payne F, Smyth DJ, Pask R, Cooper JD, Masters J, Wang WYS, Godfrey LM, Bowden G, Szeszko J, Smink LJ, Lam AC, Burren O, Walker NM, Nutland S, Rance H, Undlien DE, Rønningen KS, Guja C, Ionescu-Tîrgovişte C, Todd JA, Twells RCJ. No evidence for association of the TATA-box binding protein glutamine repeat sequence or the flanking chromosome 6q27 region with type 1 diabetes. Biochem Biophys Res Commun. 2005;331(2):435-41. https://doi.org/10.1016/j.bbrc.2005.03.203

35. Pandey R, Bhattacharya A, Bhardwaj V, Jha V, Mandal AK, Mukerji M. Alu-miRNA interactions modulate transcript isoform diversity in stress response and reveal signatures of positive selection. Int J Sci Reports. 2016;6:32348. https://doi.org/10.1038/srep32348

36. Chiou J, Geusz RJ, Okino ML, Han IJY, Miller M, Melton R, Beebe E, Benaglio P, Huang S, Korgaonkar K, Heller S, Kleger A, Preissl S, Gorkin DU, Sander M, Gaulton KJ. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature. 2021;594(7863):398-402. https://doi.org/10.1038/s41586-021-03552-w

37. Xie Z, Nagarajan V, Sturdevant DE, Iwaki S, Chan E, Wisch L, Young M, Nelson CM, Porcella SF, Druey KM. Genome-wide SNP analysis of the Systemic Capillary Leak Syndrome (Clarkson disease). Rare Diseases. 2013;1(1):e27445. https://doi.org/10.4161/rdis.27445

38. Morris JA, Kemp JP, Youlten SE, Laurent L, Logan JG, Chai RC, Vulpescu NA, Forgetta V, Kleinman A, Mohanty ST, Sergio CM, Quinn J, Nguyen-Yamamoto L, Luco AL, Vijay J, Simon MM, Pramatarova A, Medina-Gomez C, Trajanoska K, Ghirardello EJ, Butterfield NC, Curry KF, Leitch VD, Sparkes PC, Adoum AT, Mannan NS, Komla-Ebri DSK, Pollard AS, Dewhurst HF, Hassall TAD, Beltejar MG; 23andMe Research Team; Adams DJ, Vaillancourt SM, Kaptoge S, Baldock P, Cooper C, Reeve J, Ntzani EE, Evangelou E, Ohlsson C, Karasik D, Rivadeneira F, Kiel DP, Tobias JH, Gregson CL, Harvey NC, Grundberg E, Goltzman D, Adams DJ, Lelliott CJ, Hinds DA, Ackert-Bicknell CL, Hsu YH, Maurano MT, Croucher PI, Williams GR, Bassett JHD, Evans DM, Richards JB. An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet. 2019;51(2):258-266. https://doi.org/ 10.1038/s41588-018-0302-x

39. Kim SK. Identification of 613 new loci associated with heel bone mineral density and a polygenic risk score for bone mineral density, osteoporosis and fracture. PLoS One. 2018;13(7):e0200785. https:// doi.org/ 10.1371/journal.pone.0200785

40. Mayén-Lobo YG, Martínez-Magaña JJ, Pérez-Aldana BE, Ortega-Vázquez A, Genis-Mendoza AD, de Montellano DJD-O, Soto-Reyes E, Nicolini H, López-López M, Monroy-Jaramillo N. Integrative Genomic-Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis. Pharmaceuticals (Basel). 2021;14(2):118. https://doi.org/10.3390/ph14020118

41. Wong ML, Dong C, Andreev V, Licinio J. Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors. Mol Psychiatry. 2012;17(6):624-33. https://doi.org/10.1038/mp.2012.13

42. Vuckovic D, Bao EL, Akbari P, Lareau CA, Mousas A, Jiang T, Chen MH, Raffield LM, Tardaguila M, Huffman JE, Ritchie SC, Megy K, Ponstingl H, Penkett CJ, Albers PK, Wigdor EM, Sakaue S, Moscati A, Manansala R, Lo KS, Qian H, Akiyama M, Bartz TM, Ben-Shlomo Y, Beswick A, Bork-Jensen J, Bottinger EP, Brody JA, van Rooij FJA, Chitrala KN, Wilson PWF, Choquet H, Danesh J, Di Angelantonio E, Dimou N, Ding J, Elliott P, Esko T, Evans MK, Felix SB, Floyd JS, Broer L, Grarup N, Guo MH, Guo Q, Greinacher A, Haessler J, Hansen T, Howson JMM, Huang W, Jorgenson E, Kacprowski T, Kähönen M, Kamatani Y, Kanai M, Karthikeyan S, Koskeridis F, Lange LA, Lehtimäki T, Linneberg A, Liu Y, Lyytikäinen LP, Manichaikul A, Matsuda K, Mohlke KL, Mononen N, Murakami Y, Nadkarni GN, Nikus K, Pankratz N, Pedersen O, Preuss M, Psaty BM, Raitakari OT, Rich SS, Rodriguez BAT, Rosen JD, Rotter JI, Schubert P, Spracklen CN, Surendran P, Tang H, Tardif JC, Ghanbari M, Völker U, Völzke H, Watkins NA, Weiss S; VA Million Veteran Program; Cai N, Kundu K, Watt SB, Walter K, Zonderman AB, Cho K, Li Y, Loos RJF, Knight JC, Georges M, Stegle O, Evangelou E, Okada Y, Roberts DJ, Inouye M, Johnson AD, Auer PL, Astle WJ, Reiner AP, Butterworth AS, Ouwehand WH, Lettre G, Sankaran VG, Soranzo N. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell. 2020;182(5):1214-1231.e11. doi: 10.1016/j.cell.2020.08.008. PMID: 32888494; PMCID: PMC7482360.

43. Hodonsky CJ, Jain D, Schick UM, Morrison JV, Brown L, McHugh CaP, Schurmann C, Chen DD, Liu YM, Auer PL, Laurie CA, Taylor KD, Browning BL, Li Y, Papanicolaou G, Rotter JI, Kurita R, Nakamura Y, Browning SR, Ruth Loos JF, North KE, Laurie CC, Thornton TA, Pankratz N, Bauer DE, Sofer T, Reiner AP. Genomewide association study of red blood cell traits in Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos. PLoS Genet. 2017;13(4):e1006760. https://doi.org/10.1371/journal.pgen.1006760

44. Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, Mead D, Bouman H, Riveros-Mckay F, Kostadima MA, Lambourne JJ, Sivapalaratnam S, Downes K, Kundu K, Bomba L, Berentsen K, Bradley JR, Daugherty LC, Delaneau O, Freson K, Garner SF, Grassi L, Guerrero J, Haimel M, Janssen-Megens EM, Kaan A, Kamat M, Kim B, Mandoli A, Marchini J, Martens JHA, Meacham S, Megy K, O'Connell J, Petersen R, Sharifi N, Sheard SM, Staley JR, Tuna S, van der Ent M, Walter K, Wang SY, Wheeler E, Wilder SP, Iotchkova V, Moore C, Sambrook J, Stunnenberg HG, Di Angelantonio E, Kaptoge S, Kuijpers TW, Carrillo-de-Santa-Pau E, Juan D, Rico D, Valencia A, Chen L, Ge B, Vasquez L, Kwan T, Garrido-Martín D, Watt S, Yang Y, Guigo R, Beck S, Paul DS, Pastinen T, Bujold D, Bourque G, Frontini M, Danesh J, Roberts DJ, Ouwehand WH, Butterworth AS, Soranzo N. The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell. 2016;167(5):1415-1429. e19. https://doi.org/10.1016/j.cell.2016.10.042

45. Surendran P., Feofanova E.V., Lahrouchi N., Ntalla I., Karthikeyan S. et al Genetic association and Mendelian randomization for hypothyroidism highlight immune molecular mechanisms. iScience. 2022;25(9):104992. https://doi.org/10.1016/j.isci.2022.104992

46. Surendran P, Feofanova EV, Lahrouchi N, Ntalla I, Karthikeyan S, et al. Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. Nat Genet. 2020;52(12):1314-1332. https://doi.org/10.1038/s41588-020-00713-x

47. Chiquet BT, Hashmi SS, Henry R, Burt A, Mulliken JB, Stal S, Bray M, Blanton SH, Hecht JT. Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate. Eur. J. Hum. Genet. 2009;17(2):195-204. https:// doi.org/10.1038/ejhg.2008.149